Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Assets Average (2022 - 2026)

Orchestra BioMed Holdings has reported Assets Average over the past 5 years, most recently at $107.8 million for Q1 2026.

  • Quarterly Assets Average rose 59.38% to $107.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $107.8 million through Mar 2026, up 59.38% year-over-year, with the annual reading at $95.5 million for FY2025, 11.46% up from the prior year.
  • Assets Average was $107.8 million for Q1 2026 at Orchestra BioMed Holdings, down from $109.8 million in the prior quarter.
  • Over five years, Assets Average peaked at $161.7 million in Q1 2022 and troughed at $50.9 million in Q2 2025.
  • The 5-year median for Assets Average is $105.8 million (2023), against an average of $101.2 million.
  • Year-over-year, Assets Average tumbled 40.87% in 2024 and then soared 59.38% in 2026.
  • A 5-year view of Assets Average shows it stood at $82.1 million in 2022, then rose by 28.83% to $105.8 million in 2023, then decreased by 28.4% to $75.7 million in 2024, then skyrocketed by 45.0% to $109.8 million in 2025, then decreased by 1.89% to $107.8 million in 2026.
  • Per Business Quant, the three most recent readings for OBIO's Assets Average are $107.8 million (Q1 2026), $109.8 million (Q4 2025), and $73.8 million (Q3 2025).